Institute of Chemical Biology and Drug Discovery

Therapeutic Approaches: Biologics, Small Molecules, Biomarkers, Antibodies, Stem Cells, Gene Therapy, Drug Delivery

Therapeutic Areas of Expertise: Infectious Diseases, Neurological Disorders, Oncology, Pain

Center/Program Highlights:The ICB&DD integrates the existing strengths at Stony Brook in the medical and molecular sciences, and brings in complementary expertise from outside to explore drug discovery and development. Currently, ICB&DD is focusing on drug discovery in: ?Cancer Therapeutics ?Therapeutics for Infectious Diseases ?Diagnostics/Therapeutics for Alzheimer's and Parkinsons Diseases ?Anti-Inflammatory Therapeutics In order to promote drug discovery in these areas, ICB&DD has implemented the state-of-the-art Discovery Chemistry Laboratory and the Bioanalytical Instrumentation Laboratory, which serve for the members of the Institute.

Sources of Funding: Federal/State, Philanthropy, Industry Partnerships, University

Industrial Partnerships: Sanofi, Astrazeneca, ChemMaster International,


Institutional Affiliation(s): Stony Brook University, State University of New York

The Chemistry Bldg., John S. Toll Drive
Stony Brook University
Stony Brook
New York, 11794-3400
United States

Center/Program Start Date: 2004

Number of Employees: 60